Reply to 'Selective effects of heterozygous protein-truncating variants'

Affiliations

• ¹ Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ² Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
• ³ Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.
• ⁴ Centre for Genomic Regulation, Barcelona, Spain.
• ⁵ Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁶ Analytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
• ⁷ Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.
• ⁸ Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
• ⁹ Center for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, USA. david.beier@seattlechildrens.org.
• ¹⁰ Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. david.beier@seattlechildrens.org.
• ¹¹ Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. ssunyaev@rics.bwh.harvard.edu.
• ¹² Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. ssunyaev@rics.bwh.harvard.edu.
• ¹³ Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA. ssunyaev@rics.bwh.harvard.edu.